– Prioritization of Phase 2-ready clinical-stage programs: RLYB212 for the prevention of FNAIT and RLYB116, a C5 inhibitor for the treatment of patients with complement-mediated diseases – – ...

Company AnnouncementGenmab to discontinue clinical development of acasunlimab following a portfolio reviewDecision reflects prioritization of ...

Highest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for meaningful value creation Company to ...

AUSTIN, Texas--(BUSINESS WIRE)--Planview®, the global leader in Portfolio Management and Work Management, today announced the acquisition of Enrich, a product portfolio analytics company that empowers ...

Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results Annual cash burn will be reduced to approximately $50 million from approximately $80 ...

SEATTLE, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced a portfolio ...

- Phase 1 study of CNTY-101, Company's lead candidate targeting CD19, in relapsed/refractory B-cell lymphoma remains on track; No impact to partnered programs with Bristol Myers Squibb - PHILADELPHIA, ...

When providing technical support for a university as vast and multifaceted as UB, it is crucial for an IT department to use some form of project portfolio prioritization—a system meant to ensure that ...

Prioritizing effectively in a global SaaS company with hundreds or thousands of customers across the world is not a straightforward proposition. Almost everyone in product management knows that it’s ...